Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

<< Previous

Bullboard Posts

Next >>

Post by steadfaston Jan 06, 2022 9:43pm

276 Views

Post# 34291503

Are we on the way to $3.48 short term????

Redbaron, agree with you. $1B U.S. as Minimum Short Term.
$1B US = $1.27B Can div by 365 M shares fully diluted = $3.48 per share.
Hope Mgt has Press Releases ready to send immediately following Phil's
presentation to all the Press that have been giving coverage to our competition,
it is SVA's turn to get coverage. I agree with DonkeyFeathers recent post
we should be looking at $2B U.S. within next year or so. Once SVA gets to $4
we should immediately go to Nasdaq, forget about TSE, don't need to spend the
money it would cost with TSE as a stepping stone with the next goat Nasdaq,
just do it.

<< Previous

Bullboard Posts

Next >>

The long-term forecast for lithium stocks in 2024